| Literature DB >> 26912905 |
Bernhard Mlecnik1, Gabriela Bindea1, Amos Kirilovsky1, Helen K Angell2, Anna C Obenauf3, Marie Tosolini1, Sarah E Church1, Pauline Maby1, Angela Vasaturo1, Mihaela Angelova1, Tessa Fredriksen1, Stéphanie Mauger1, Maximilian Waldner4, Anne Berger5, Michael R Speicher3, Franck Pagès6, Viia Valge-Archer7, Jérôme Galon1.
Abstract
Although distant metastases account for most of the deaths in cancer patients, fundamental questions regarding mechanisms that promote or inhibit metastasis remain unanswered. We show the impact of mutations, genomic instability, lymphatic and blood vascularization, and the immune contexture of the tumor microenvironment on synchronous metastases in large cohorts of colorectal cancer patients. We observed large genetic heterogeneity among primary tumors, but no major differences in chromosomal instability or key cancer-associated mutations. Similar patterns of cancer-related gene expression levels were observed between patients. No cancer-associated genes or pathways were associated with M stage. Instead, mutations of FBXW7 were associated with the absence of metastasis and correlated with increased expression of T cell proliferation and antigen presentation functions. Analyzing the tumor microenvironment, we observed two hallmarks of the metastatic process: decreased presence of lymphatic vessels and reduced immune cytotoxicity. These events could be the initiating factors driving both synchronous and metachronous metastases. Our data demonstrate the protective impact of the Immunoscore, a cytotoxic immune signature, and increased marginal lymphatic vessels, against the generation of distant metastases, regardless of genomic instability.Entities:
Mesh:
Year: 2016 PMID: 26912905 DOI: 10.1126/scitranslmed.aad6352
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956